This animal model study investigated whether BPC 157, a synthetic peptide, could protect against organ damage in distant organs (liver, kidney, and lung) following lower-extremity ischemia-reperfusion injury in rats. The researchers found that BPC 157 treatment reduced markers of organ damage and inflammatory responses in these distant organs compared to untreated controls. This is an animal model study with no direct human clinical evidence.